Bearish Stocks at NASDAQ: Conatus Pharmaceuticals (NASDAQ:CNAT), Metabolix (NASDAQ:MBLX), Clovis Oncology (NASDAQ:CLVS), Oculus Innovative Sciences (NASDAQ:OCLS)

On March 27, 2014, Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) issued a press release announcing its financial results for the quarter and year ended December 31, 2013. Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) stock performance was -15.63% in last session and finished the day at $8.42. Traded volume was 1.28 million shares in the last session and the average volume of the stock remained 473,716.00 shares. Conatus Pharmaceuticals Inc. … Continue reading Bearish Stocks at NASDAQ: Conatus Pharmaceuticals (NASDAQ:CNAT), Metabolix (NASDAQ:MBLX), Clovis Oncology (NASDAQ:CLVS), Oculus Innovative Sciences (NASDAQ:OCLS)

Biotech Unusual Volume: Capstone Therapeutics (OTCMKTS:CAPS), Xencor (NASDAQ:XNCR), Durata Therapeutics (NASDAQ:DRTX), Clovis Oncology (NASDAQ:CLVS)

Capstone Therapeutics Corp. (OTCMKTS:CAPS) and its joint venture affiliate, LipimetiX Development, LLC (“JV”), today will hold a conference call and webcast to provide an operating update, discuss the start of AEM-28 Phase 1 clinical studies and report financial results for the fiscal year 2013. Capstone Therapeutics Corp. (OTCMKTS:CAPS) stock performance was 4.00% in last session and finished the day at $0.260. Traded volume was 57,580.00million … Continue reading Biotech Unusual Volume: Capstone Therapeutics (OTCMKTS:CAPS), Xencor (NASDAQ:XNCR), Durata Therapeutics (NASDAQ:DRTX), Clovis Oncology (NASDAQ:CLVS)

NASDAQ most Volatile: InterMune Inc (NASDAQ:ITMN), ACADIA Pharmaceuticals (NASDAQ:ACAD), Clovis Oncology (NASDAQ:CLVS), Synageva BioPharma (NASDAQ:GEVA)

Board of Directors of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) adopted an updated annual incentive cash compensation program for its executive officers to be effective beginning with 2014. The description of this program is set forth in Exhibit 99.1 and is incorporated herein by reference. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) dropped -6.61 percent to $26.01 Friday on volume of 3.37million shares. The intra-day range of the stock was … Continue reading NASDAQ most Volatile: InterMune Inc (NASDAQ:ITMN), ACADIA Pharmaceuticals (NASDAQ:ACAD), Clovis Oncology (NASDAQ:CLVS), Synageva BioPharma (NASDAQ:GEVA)

Stocks in Focus: Pingtan Marine Enterprise Ltd. (NASDAQ:PME), International Rectifier Corporation (NYSE:IRF), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Clovis Oncology (NASDAQ:CLVS), Endo International (NASDAQ:ENDP)

Pingtan Marine Enterprise Ltd. (NASDAQ:PME) announced that the Company has declared a cash dividend of $0.01 per share of common stock outstanding, payable in cash on or about February 18, 2015 to shareholders of record on January 22, 2015. This marks the second consecutive quarterly dividend paid by the Company, which it intends to continue paying on a quarterly basis. Pingtan Marine Enterprise Ltd. (NASDAQ:PME) … Continue reading Stocks in Focus: Pingtan Marine Enterprise Ltd. (NASDAQ:PME), International Rectifier Corporation (NYSE:IRF), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Clovis Oncology (NASDAQ:CLVS), Endo International (NASDAQ:ENDP)

Fast Moving Stocks: Macy’s, Inc. (NYSE:M), Array BioPharma (NASDAQ:ARRY), British American Tobacco (NYSEMKT:BTI), Crossroads Systems, Inc. (NASDAQ:CRDS), Clovis Oncology, Inc. (NASDAQ:CLVS)

Macy’s, Inc. (NYSE:M) is a chain of departmental stores that sells an assortment of fashion products for both men and women.Best Buy Co Inc (NYSE:BBY) sells electronics such as computers, cellphones, video games, and several other tech products. On the other hand, Time Warner Cable Inc (NYSE:TWC) is a cable telecommunications company that operates in many US States.Macy’s, Inc. (NYSE:M) belongs to Services sector. Its … Continue reading Fast Moving Stocks: Macy’s, Inc. (NYSE:M), Array BioPharma (NASDAQ:ARRY), British American Tobacco (NYSEMKT:BTI), Crossroads Systems, Inc. (NASDAQ:CRDS), Clovis Oncology, Inc. (NASDAQ:CLVS)

Hot News: Clovis Oncology (NASDAQ:CLVS), Nokia Corporation (ADR) (NYSE:NOK), Key Technology (NASDAQ:KTEC), The First Bancorp (NASDAQ:FNLC), Capital One Financial (NYSE:COF)

Leerink Swann initiated coverage on shares of Clovis Oncology (NASDAQ:CLVS) in a research report released on Friday morning. The firm issued an outperform rating and a $100.00 price objective on the stock. Clovis Oncology, Inc. (NASDAQ:CLVS) belongs to Healthcare sector. Its weekly performance is 11.49%. On last trading day company shares ended up $48.61. Clovis Oncology, Inc. (NASDAQ:CLVS) distance from 50-day simple moving average (SMA50) is 20.42%. … Continue reading Hot News: Clovis Oncology (NASDAQ:CLVS), Nokia Corporation (ADR) (NYSE:NOK), Key Technology (NASDAQ:KTEC), The First Bancorp (NASDAQ:FNLC), Capital One Financial (NYSE:COF)